CAV1 and Lassa fever: Furthermore, our in vitro and in vivo data indicated that the therapeutic effects of hPMSCs are achieved partly through inhibition of the TGF-/Smad signaling pathway via upregulation of Cav1 in activated HSCs, which resulted in inhibited HSC activation and alleviated LF.